Bentley Pharmaceuticals To Release Second Quarter 2005 Earnings after the Market Closes on Wednesday, August 3, 2005 and Host Conference Call and Webcast on Thursday, August 4, 2005.EXETER, N.H. -- Bentley Pharmaceuticals, Inc. (NYSE NYSE See: New York Stock Exchange :BNT BNT Bentley Pharmaceuticals, Inc. (stock symbol) BNT Boston Naming Test (psychology) BNT Bermuda National Trust BNT Bulgarian National TV BNT Broadband Network Termination BNT Binary File Transfer ), a technology- based specialty pharmaceutical and drug delivery company with a growing branded and generic product line in Europe, today announced that it will release its 2005 second quarter results for the six months ended June 30, 2005 after the market closes on Wednesday, August 3, 2005. Management will host a conference call to discuss the second quarter results and provide a business update at 10:00 a.m. Eastern Time on Thursday, August 4, 2005. To participate on the live call, please dial (866) 203-3436 from the U.S. or, for international callers, please dial (617) 213-8849 (passcode #20943338), approximately 15 minutes prior to the scheduled start time. A telephone replay will be available for 30 days by dialing (888) 286-8010 from the U.S. or (617) 801-6888 for international callers (passcode #24349454). The conference call will also be broadcast live on the Internet and may be accessed via Bentley's web site, www.bentleypharm.com. Please go to the Company's web site approximately 15 minutes prior to the scheduled start time to register, download To receive a file transmitted over a network. In any communications session, "download" means receive, and "upload" means send. The download/upload often implies a big/little scenario, in which data is being downloaded from the "big" server into the "little" user's computer. and install any necessary audio software. A replay of the conference will also be available on Bentley's web site for 30 days. Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on advanced drug delivery technologies and pharmaceutical products. Bentley's proprietary drug technologies enhance or facilitate the absorption of pharmaceutical compounds across various membranes. Bentley also manufactures and markets a growing portfolio of generic and branded pharmaceuticals in Europe for the treatment of cardiovascular cardiovascular /car·dio·vas·cu·lar/ (-vas´ku-ler) pertaining to the heart and blood vessels. car·di·o·vas·cu·lar adj. Abbr. , gastrointestinal gastrointestinal /gas·tro·in·tes·ti·nal/ (-in-tes´ti-n'l) pertaining to or communicating with the stomach and intestine. gas·tro·in·tes·ti·nal adj. Abbr. , infectious and neurological diseases Noun 1. neurological disease - a disorder of the nervous system nervous disorder, neurological disorder disorder, upset - a physical condition in which there is a disturbance of normal functioning; "the doctor prescribed some medicine for the disorder"; through its subsidiaries, Laboratorios Belmac, Laboratorios Davur and Laboratorios Rimafar; and manufactures and markets active pharmaceutical ingredients through its subsidiary, Bentley API (Application Programming Interface) A language and message format used by an application program to communicate with the operating system or some other control program such as a database management system (DBMS) or communications protocol. . Copies of Bentley Pharmaceuticals' press releases and other information may be obtained through Bentley's web site at www.bentleypharm.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion